Two Doses of China’s Sinovac Inadequate Against Omicron, Hong Kong Study Suggests
A new study looking at blood samples from people who received two doses of a Covid-19 vaccine made by the Chinese pharmaceutical company Sinovac suggested that the vaccine would be unable to prevent an infection of the new, highly infectious Omicron variant.The research, which analyzed the blood of 25 people vaccinated with Sinovac, is the latest sign of the new challenge Omicron presents as it spreads across the world. The […]